{"id":268721,"date":"2025-07-15T00:03:13","date_gmt":"2025-07-15T00:03:13","guid":{"rendered":"https:\/\/www.europesays.com\/de\/268721\/"},"modified":"2025-07-15T00:03:13","modified_gmt":"2025-07-15T00:03:13","slug":"neue-zulassungsempfehlungen-fuer-onkologische-therapien","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/de\/268721\/","title":{"rendered":"Neue Zulassungsempfehlungen f\u00fcr onkologische Therapien"},"content":{"rendered":"<p>&#13;<br \/>\n\t\t\t\t\tGelbe Liste Online ist ein Online-Dienst der&#13;<br \/>\n\t\t\t\t\tVidal MMI Germany GmbH (Vidal MMI) und bietet News, Infos und&#13;<br \/>\n\t\t\t\t\tDatenbanken f\u00fcr \u00c4rzte,&#13;<br \/>\n\t\t\t\t\tApotheker und andere medizinische Fachkreise. Die&#13;<br \/>\n\t\t\t\t\tGELBE LISTE PHARMINDEX ist ein f\u00fchrendes Verzeichnis von Wirkstoffen,&#13;<br \/>\n\t\t\t\t\tMedikamenten,&#13;<br \/>\n\t\t\t\t\tMedizinprodukten, Di\u00e4tetika,&#13;<br \/>\n\t\t\t\t\tNahrungserg\u00e4nzungsmitteln, Verbandmitteln und Kosmetika.&#13;\n\t\t\t\t<\/p>\n","protected":false},"excerpt":{"rendered":"&#13; Gelbe Liste Online ist ein Online-Dienst der&#13; Vidal MMI Germany GmbH (Vidal MMI) und bietet News, Infos&hellip;\n","protected":false},"author":2,"featured_media":268722,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[137],"tags":[81035,81034,81037,81032,81033,29,30,141,232,81036,81031],"class_list":{"0":"post-268721","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-gesundheit","8":"tag-multiples-myelom","9":"tag-neuroendokrine-tumoren","10":"tag-onkologische-therapien","11":"tag-chmp","12":"tag-desmoidtumor","13":"tag-deutschland","14":"tag-germany","15":"tag-gesundheit","16":"tag-health","17":"tag-mantelzell-lymphom","18":"tag-zulassungsempfehlung"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@de\/114854324194764172","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/268721","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/comments?post=268721"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/268721\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media\/268722"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media?parent=268721"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/categories?post=268721"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/tags?post=268721"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}